Sees FY 24 Non-GAAP gross margin of 74% to 76%. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on PCRX: Pacira reports Q3 EPS 79c, consensus 70c Pacira announces CMS established additional payment for iovera in outpatient Pacira (PCRX) Q3 Earnings Cheat Sheet Pacira Pharmaceuticals Appoints Shawn Cross as CFO Pacira appoints Cross as Chief Financial Officer